poisar

Stocks · News reference

UnitedHealth, Abbott Laboratories And 3 Stocks To Watch Heading Into Thursday

Jul 16, 2026, 7:18 AMAvi Kapoor

US stock futures mixed, investors to focus on UnitedHealth, J B Hunt, Abbott, TSMC and GE Aerospace earnings. TSM beats expectations.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ABTGEJBHTTSMUNH
Source
benzinga
Observed
Jul 16, 2026, 7:18 AM
Checked
Jul 16, 2026, 7:18 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 5:00 PMDelveinsight

    Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight

    The global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.

    Read original at globenewswire-inc
    RHHBYABTTMODGXLH
  2. Aug 27, 2026, 3:00 PMSns Insider

    Laboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS Insider

    The global laboratory informatics market is projected to grow at a CAGR of 5.06% from 2025 to 2035, driven by increased data processing demands, regulatory compliance requirements, and adoption of cloud-native solutions and AI-driven analytics. North America leads with 42.55% market share, while Asia-Pacific is the fastest-growing region. Services and LIMS products dominate, with cloud delivery and electronic lab notebooks showing the strongest growth rates.

    Read original at globenewswire-inc
    TMOAABTWATDHR
  4. Aug 26, 2026, 11:57 AMResearchandmarkets.Com

    Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic

    The global atrial fibrillation treatment devices market is expected to grow at a 13.1% CAGR from $9.6 billion in 2026 to $29 billion by 2035, driven by aging populations, rising AF prevalence affecting 50-60 million people worldwide, and increasing adoption of advanced ablation and left atrial appendage closure technologies. Pulsed field ablation is forecast to generate over 60% of market revenue by 2035, while North America will retain approximately 50% of global market share. Asia-Pacific is expected to register the fastest regional growth.

    Read original at globenewswire-inc
    ABTBSXATRCMDTJNJ
  5. Aug 27, 2026, 4:21 PMNa

    Can GE Aerospace Boost Profit Margin Amid Cost Pressures?

    GE Aerospace reported Q2 2026 operating profit of $2.75B, up 18% year-over-year, but operating margins declined 130 basis points to 21.7% due to growth investments and cost inflation. The company raised its 2026 operating profit guidance to $10.55-$10.75B, implying 17% growth at midpoint, driven by strong commercial and defense aerospace demand and higher LEAP engine deliveries.

    Read original at zacks-investment-research
    GERTXTXT
  6. Aug 25, 2026, 12:07 AMBrendan Coffey

    ITA vs JETS: Which Is the High Flying Airline and Aerospace ETF to Profit From in 2026?

    The article compares two aerospace ETFs: iShares U.S. Aerospace & Defense ETF (ITA) and U.S. Global Jets ETF (JETS). ITA focuses on defense contractors and aerospace manufacturers with a lower 0.37% expense ratio, higher 1-year return of 22.9%, and lower volatility (beta 0.74). JETS concentrates on commercial airlines with a higher 0.6% expense ratio and 16.9% 1-year return but greater volatility (beta 1.18). The article recommends ITA as the better long-term investment due to superior historical performance and stability.

    Read original at the-motley-fool
    ITAJETSGERTXBA